Top Line Results Announced From Two Bipolar Depression Studies

July 16, 2019

Lumateperone, an investigational drug from Intra-Cellular Therapies, Inc., posted varied results in two phase 3 clinical trials evaluating it as a monotherapy for major depressive episodes associated with bipolar disorder. Read More >>

BHAP Logo

A national membership association that provides education and advocacy for those in the behavioral health and addiction treatment industries.

We are the leading and unifying voice of addiction-focused treatment programs.

Join Now


Contact Us


Hours
Monday - Friday
8:30 am - 4:30 pm Pacific
(closed major holidays)